Antibodies under a microscope

DHE03401

Research Grade Galiximab

Description

IDEC-114, CAS: 357613-77-5

Targets

CD80, BB1, T-lymphocyte activation antigen CD80, CD28LG, B7, CD28LG1, LAB7, Activation B7-1 antigen, CTLA-4 counter-receptor B7.1

Isotype/Mimetic

IgG1-lambda

Animal-Derived Biomaterials Used

None

Sequence Available

No

Original Discovery Method

Unknown

Original Discovery Information Provided On Datasheet

No

Antibody/Binder Origins

Unknown discovery source/method, In vitro recombinant expression